| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | CC2D1A NFATC1 VAX2 BATF3 RARA IRX3 BHLHE40 ZNF692 E2F8 TGIF1 KLF16 OVOL1 | 5.22e-05 | 326 | 184 | 12 | GO:0001217 |
| Domain | NPIP | 3.03e-11 | 14 | 188 | 7 | IPR009443 | |
| Domain | DUF4599 | 7.33e-08 | 12 | 188 | 5 | PF15371 | |
| Domain | DUF4599 | 7.33e-08 | 12 | 188 | 5 | IPR027970 | |
| Domain | IB | 2.72e-05 | 18 | 188 | 4 | SM00121 | |
| Domain | Growth_fac_rcpt_ | 2.93e-05 | 156 | 188 | 9 | IPR009030 | |
| Domain | IGFBP | 4.25e-05 | 20 | 188 | 4 | PF00219 | |
| Domain | IGFBP-like | 4.25e-05 | 20 | 188 | 4 | IPR000867 | |
| Domain | IGFBP_N_2 | 4.25e-05 | 20 | 188 | 4 | PS51323 | |
| Domain | IPT | 1.46e-04 | 27 | 188 | 4 | SM00429 | |
| Domain | BAH | 1.56e-04 | 11 | 188 | 3 | PS51038 | |
| Domain | BAH_dom | 1.56e-04 | 11 | 188 | 3 | IPR001025 | |
| Domain | BAH | 1.56e-04 | 11 | 188 | 3 | SM00439 | |
| Domain | BAH | 1.56e-04 | 11 | 188 | 3 | PF01426 | |
| Domain | IPT | 2.87e-04 | 32 | 188 | 4 | IPR002909 | |
| Domain | IGFBP_rP_mac25 | 3.00e-04 | 3 | 188 | 2 | IPR011390 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 RNF223 PPRC1 C15orf39 CC2D1A FAM110A MBD6 CIC RYR1 MXRA7 CABLES1 TNRC18 NFATC1 NFKB2 SEC16A MAP3K11 CACNA1H WDR90 DOCK6 WNK2 BAHCC1 PLXNA3 NDST1 EP400 SH2B3 CTC1 TRMT1 BAHD1 EML3 MICALL1 RABL6 RADIL KMT2D OVOL1 SCAP SLC45A1 CABIN1 ARHGAP33 | 4.77e-19 | 1105 | 199 | 38 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L MYO9A MAPT PAK4 KCTD8 CC2D1A RTKN N4BP3 CIC ENKD1 TBC1D1 SEC16A ZNF598 DOCK6 KIF2C SASH1 KIF26B DBNL CCDC85C CBX4 PLEKHG2 NCKAP5L AKT1S1 E2F8 MICALL1 RADIL SLF2 LPP R3HDM1 | 1.88e-14 | 861 | 199 | 29 | 36931259 |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 7.35e-07 | 4 | 199 | 3 | 18055785 | |
| Pubmed | 3.64e-06 | 6 | 199 | 3 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 3.64e-06 | 6 | 199 | 3 | 25930072 | |
| Pubmed | Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. | 6.35e-06 | 7 | 199 | 3 | 12101239 | |
| Pubmed | Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. | 1.01e-05 | 8 | 199 | 3 | 21447625 | |
| Pubmed | 1.05e-05 | 130 | 199 | 7 | 12421765 | ||
| Pubmed | PAK4 RTKN TBC1D1 SEC16A DOCK6 KIF2C CCDC85C NCKAP5L AKT1S1 RADIL R3HDM1 ALG13 | 1.13e-05 | 446 | 199 | 12 | 24255178 | |
| Pubmed | PAK4 NACA NFASC WDR90 DOCK6 WNK2 SASH1 EP400 JADE2 DIDO1 FNDC3A BAHD1 MICALL1 | 1.28e-05 | 529 | 199 | 13 | 14621295 | |
| Pubmed | The sequence and analysis of duplication-rich human chromosome 16. | 1.36e-05 | 90 | 199 | 6 | 15616553 | |
| Pubmed | GCM2 TOX KIF1A CIC PGR PLXNA3 RARA JADE2 DIDO1 IRX3 BHLHE40 ZNF692 TGIF1 OVOL1 TRIM47 | 1.61e-05 | 709 | 199 | 15 | 22988430 | |
| Pubmed | GCM2 TOX CIC KAT2B NFATC1 NFKB2 ZNF598 UTF1 PLXNA3 RARA DIDO1 BHLHE40 TGIF1 KLF16 OVOL1 LPP | 1.88e-05 | 808 | 199 | 16 | 20412781 | |
| Pubmed | MYO9A PAK4 CIC ENKD1 POM121 MAP3K11 WNK2 JADE2 KIF26B NCKAP5L BHLHE40 ARHGAP33 | 2.64e-05 | 486 | 199 | 12 | 20936779 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PAK4 C15orf39 CC2D1A TYSND1 RTKN N4BP3 ENKD1 NFKB2 SEC16A DOCK6 RBMS2 CCDC85C NCKAP5L AKT1S1 RABL6 SHROOM1 LPP R3HDM1 | 3.25e-05 | 1038 | 199 | 18 | 26673895 |
| Pubmed | N4BP3 promotes angiogenesis in hepatocellular carcinoma by binding with KAT2B. | 3.26e-05 | 2 | 199 | 2 | 35848906 | |
| Pubmed | Cyclooxygenase-2 immunoexpression in breast cancer: progesterone receptor influence. | 3.26e-05 | 2 | 199 | 2 | 21840784 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 18668363 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 29101244 | ||
| Pubmed | The roles of CC2D1A and HTR1A gene expressions in autism spectrum disorders. | 3.26e-05 | 2 | 199 | 2 | 26782176 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 21090244 | ||
| Pubmed | NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2. | 3.26e-05 | 2 | 199 | 2 | 25738651 | |
| Pubmed | Senolytics prevent caveolar CaV 3.2-RyR axis malfunction in old vascular smooth muscle. | 3.26e-05 | 2 | 199 | 2 | 37837625 | |
| Pubmed | TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. | 3.26e-05 | 2 | 199 | 2 | 31207603 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 20392296 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 22873724 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 16543407 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 24657343 | ||
| Pubmed | COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion. | 3.26e-05 | 2 | 199 | 2 | 24969217 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 24036907 | ||
| Pubmed | 3.30e-05 | 32 | 199 | 4 | 19542561 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATXN2L MYO9A C15orf39 CIC NFATC1 NFKB2 TONSL SEC16A KIF2C EP400 CBX4 NCKAP5L SLF2 | 3.82e-05 | 588 | 199 | 13 | 38580884 |
| Pubmed | 3.91e-05 | 12 | 199 | 3 | 15342473 | ||
| Pubmed | Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. | 3.93e-05 | 66 | 199 | 5 | 15790807 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SPATA31E1 APC2 CIC ZNF469 TNRC18 POM121 TONSL WDR90 NYAP1 WNK2 EP400 | 4.17e-05 | 430 | 199 | 11 | 35044719 |
| Pubmed | Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131. | 4.25e-05 | 110 | 199 | 6 | 26841866 | |
| Pubmed | ATXN2L CEP76 MBD6 SSPOP ADCY6 CIC POM121 WNK2 RARA RADIL ADAM33 R3HDM1 ALG13 | 5.36e-05 | 608 | 199 | 13 | 16713569 | |
| Pubmed | FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice. | 6.59e-05 | 38 | 199 | 4 | 26134413 | |
| Pubmed | MAPT PAK4 NACA CC2D1A PLD3 MXRA7 POM121 SEC16A ZNF598 DBNL CCDC85C AKT1S1 MICALL1 COL18A1 LPP R3HDM1 TRIM47 | 7.51e-05 | 1007 | 199 | 17 | 34597346 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | C15orf39 RTKN ENKD1 CABLES1 SEC16A ZNF598 NOTCH3 FBXO31 ARHGAP33 | 7.52e-05 | 307 | 199 | 9 | 37499664 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | GCM2 NFATC1 NFKB2 VAX2 BATF3 RARA IRX3 BHLHE40 E2F8 TGIF1 KLF16 OVOL1 | 7.77e-05 | 544 | 199 | 12 | 28473536 |
| Pubmed | 7.98e-05 | 15 | 199 | 3 | 16510875 | ||
| Pubmed | MAPT ADCY6 ENKD1 ZNF469 KAT2B SEC16A DLAT VAX2 BAHCC1 EP400 C16orf96 CBX4 NCKAP5L CDH15 INO80B ARHGAP33 CDH16 ALG13 | 8.20e-05 | 1116 | 199 | 18 | 31753913 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 30321499 | ||
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 9.74e-05 | 3 | 199 | 2 | 30802453 | |
| Pubmed | Progesterone Receptor Serves the Ovary as a Trigger of Ovulation and a Terminator of Inflammation. | 9.74e-05 | 3 | 199 | 2 | 32294429 | |
| Pubmed | Freud-2/CC2D1B mediates dual repression of the serotonin-1A receptor gene. | 9.74e-05 | 3 | 199 | 2 | 21155902 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 31551514 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 22328058 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 35507432 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 36362060 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 18441095 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 15632146 | ||
| Pubmed | Genome-Wide Association Study to Identify Genes Related to Renal Mercury Concentrations in Mice. | 9.74e-05 | 3 | 199 | 2 | 26942574 | |
| Pubmed | Steroid receptor induction of gene transcription: a two-step model. | 9.74e-05 | 3 | 199 | 2 | 9223281 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 15018807 | ||
| Pubmed | An in cellulo-derived structure of PAK4 in complex with its inhibitor Inka1. | 9.74e-05 | 3 | 199 | 2 | 26607847 | |
| Pubmed | PAPA-1 Is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions. | 9.74e-05 | 3 | 199 | 2 | 19095771 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 27358460 | ||
| Pubmed | Divergent origins and concerted expansion of two segmental duplications on chromosome 16. | 9.74e-05 | 3 | 199 | 2 | 11948212 | |
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 27277673 | ||
| Pubmed | 9.74e-05 | 3 | 199 | 2 | 14581481 | ||
| Pubmed | Laminar organization of the early developing anterior hypothalamus. | 9.78e-05 | 16 | 199 | 3 | 16860307 | |
| Pubmed | 1.18e-04 | 17 | 199 | 3 | 11683995 | ||
| Pubmed | Cdc42 regulates cofilin during the establishment of neuronal polarity. | 1.94e-04 | 4 | 199 | 2 | 18045906 | |
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 21673954 | ||
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 23595990 | ||
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 27312418 | ||
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 28692043 | ||
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 1.94e-04 | 4 | 199 | 2 | 17900573 | |
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 19203995 | ||
| Pubmed | Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. | 1.94e-04 | 4 | 199 | 2 | 16024651 | |
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 26712011 | ||
| Pubmed | p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells. | 1.94e-04 | 4 | 199 | 2 | 19590511 | |
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 22492029 | ||
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 22335196 | ||
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 29688404 | ||
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 22705236 | ||
| Pubmed | A pair of E3 ubiquitin ligases compete to regulate filopodial dynamics and axon guidance. | 1.94e-04 | 4 | 199 | 2 | 31820781 | |
| Pubmed | 1.94e-04 | 4 | 199 | 2 | 19170105 | ||
| Pubmed | A digenic cause of cleft lip in A-strain mice and definition of candidate genes for the two loci. | 1.96e-04 | 20 | 199 | 3 | 15329828 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | GCM2 CIC PGR NFATC1 NFKB2 VAX2 BATF3 RARA IRX3 BHLHE40 E2F8 TGIF1 KLF16 KMT2D NEUROD6 | 2.52e-04 | 908 | 199 | 15 | 19274049 |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 2.75e-04 | 218 | 199 | 7 | 33378226 | |
| Pubmed | 3.00e-04 | 23 | 199 | 3 | 9225980 | ||
| Pubmed | Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. | 3.22e-04 | 5 | 199 | 2 | 18632614 | |
| Pubmed | 3.22e-04 | 5 | 199 | 2 | 23209664 | ||
| Pubmed | 3.22e-04 | 5 | 199 | 2 | 25771405 | ||
| Pubmed | Experience-dependent myelination following stress is mediated by the neuropeptide dynorphin. | 3.22e-04 | 5 | 199 | 2 | 34536353 | |
| Pubmed | Cdc25B functions as a novel coactivator for the steroid receptors. | 3.22e-04 | 5 | 199 | 2 | 11689696 | |
| Pubmed | 3.22e-04 | 5 | 199 | 2 | 27040987 | ||
| Pubmed | Effects of different CMV-heat-inactivation-methods on growth factors in human breast milk. | 3.22e-04 | 5 | 199 | 2 | 19127217 | |
| Pubmed | 3.22e-04 | 5 | 199 | 2 | 21413932 | ||
| Pubmed | Transcription factor-specific requirements for coactivators and their acetyltransferase functions. | 3.22e-04 | 5 | 199 | 2 | 9445475 | |
| Pubmed | Inflammatory status influences aromatase and steroid receptor expression in endometriosis. | 3.22e-04 | 5 | 199 | 2 | 18048499 | |
| Pubmed | 3.22e-04 | 5 | 199 | 2 | 23153492 | ||
| Pubmed | 3.22e-04 | 5 | 199 | 2 | 24837029 | ||
| Pubmed | 3.22e-04 | 5 | 199 | 2 | 29678817 | ||
| Pubmed | 3.22e-04 | 5 | 199 | 2 | 17389641 | ||
| Pubmed | SIRT1 plays an important role in implantation and decidualization during mouse early pregnancy. | 3.22e-04 | 5 | 199 | 2 | 35134122 | |
| Pubmed | 3.33e-04 | 225 | 199 | 7 | 12168954 | ||
| Interaction | TOP3B interactions | VWA5B2 RNF223 PPRC1 C15orf39 CC2D1A FAM110A MBD6 CIC RYR1 MXRA7 CABLES1 TNRC18 NFATC1 NFKB2 SEC16A MAP3K11 DLAT CACNA1H WDR90 ZNF598 DOCK6 WNK2 BAHCC1 PLXNA3 NDST1 EP400 SH2B3 CTC1 TRMT1 BAHD1 EML3 MICALL1 RABL6 RADIL KMT2D OVOL1 SCAP SLC45A1 CABIN1 ARHGAP33 | 5.29e-10 | 1470 | 187 | 40 | int:TOP3B |
| Interaction | YWHAH interactions | ATXN2L MYO9A MAPT PAK4 CC2D1A RTKN N4BP3 CIC CHRNA4 ENKD1 TBC1D1 SEC16A DOCK6 WNK2 KIF2C SASH1 KIF26B DBNL CCDC85C CBX4 PLEKHG2 NCKAP5L AKT1S1 EML3 E2F8 MICALL1 RADIL SHROOM1 SLF2 LPP R3HDM1 | 3.05e-08 | 1102 | 187 | 31 | int:YWHAH |
| Interaction | PNMA2 interactions | MYO9A PAK4 N4BP3 CIC ENKD1 CTC1 CCDC85C CBX4 EML3 NUTM2F INO80B | 2.38e-05 | 251 | 187 | 11 | int:PNMA2 |
| Interaction | HELZ interactions | B4GALT2 C15orf39 POM121 SEC16A WDR90 RBMS2 C9orf163 TLE2 SHARPIN R3HDM1 ALG13 | 2.95e-05 | 257 | 187 | 11 | int:HELZ |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | NPIPA1 RGS11 NPIPA5 CACNA1H NPIPA3 WDR90 ZNF598 NTN3 C16orf96 NPIPB2 | 2.09e-05 | 426 | 201 | 10 | chr16p13 |
| Cytoband | 16p13.11 | 1.37e-04 | 23 | 201 | 3 | 16p13.11 | |
| Cytoband | 11q22-q23 | 2.83e-04 | 6 | 201 | 2 | 11q22-q23 | |
| Cytoband | 5p15 | 3.95e-04 | 7 | 201 | 2 | 5p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 5.25e-04 | 8 | 201 | 2 | chr9q12 | |
| Cytoband | 16p12.2 | 5.76e-04 | 37 | 201 | 3 | 16p12.2 | |
| Cytoband | 16p13.3 | 7.60e-04 | 244 | 201 | 6 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | APC2 CC2D1A SHC2 CACTIN-AS1 DOCK6 NOTCH3 DCAF15 TRMT1 IER2 KLF16 TLE2 | 8.44e-04 | 797 | 201 | 11 | chr19p13 |
| Cytoband | 9q34.3 | 1.25e-03 | 106 | 201 | 4 | 9q34.3 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP | NACA ADAMTS16 KIF2C BAHCC1 RARA SH2B3 PLEKHG2 NCKAP5L LRRN4CL INO80B | 7.03e-07 | 174 | 193 | 10 | M6817 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | MFRP PTGS2 SVEP1 CCN4 RBMS3 DOCK6 NOTCH3 GP1BB HTR1A SASH1 SH2B3 RBMS2 KCP PLEKHG2 EML3 IER2 COL18A1 IGFBP7 LPP | 7.23e-06 | 795 | 193 | 19 | M39050 |
| Coexpression | PGF_UP.V1_DN | 1.23e-05 | 190 | 193 | 9 | M2673 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.28e-05 | 191 | 193 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.58e-05 | 196 | 193 | 9 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | VWA5B2 SSPOP IGFBPL1 SVEP1 CCN4 NTN3 KCP COL18A1 IGFBP2 IGFBP7 | 3.40e-05 | 270 | 193 | 10 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | VWA5B2 SSPOP IGFBPL1 SVEP1 CCN4 NTN3 KCP COL18A1 IGFBP2 IGFBP7 | 3.98e-05 | 275 | 193 | 10 | M5884 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | ATXN2L PPRC1 NPIPB3 RTKN CIC ZNF598 NCKAP5L ZNF692 MICALL1 KLF16 KMT2D | 4.50e-05 | 338 | 193 | 11 | M17094 |
| Coexpression | BHAT_ESR1_TARGETS_VIA_AKT1_UP | 4.77e-05 | 281 | 193 | 10 | M2234 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | DNER C15orf39 FAM110A TYSND1 CABLES1 WDR90 DOCK6 NOTCH3 PLXNA3 TENT4A DIDO1 AKT1S1 EML3 RABL6 | 7.95e-05 | 563 | 193 | 14 | M15103 |
| Coexpression | LOPEZ_MBD_TARGETS | CDKN1C C15orf39 ENKD1 SVEP1 RYR1 SEC16A MAP3K11 ATG9B RARA TENT4A FNDC3A ZNF692 AKT1S1 TGIF1 OVOL1 IGFBP2 SLC45A1 CDH15 CDH16 | 8.53e-05 | 953 | 193 | 19 | M4120 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | VWA5B2 NPIPB4 TOX KIF1A NPIPA1 RGS11 KAT2B NPIPA5 CACNA1H WNK2 BAHD1 KLF16 | 8.70e-05 | 429 | 193 | 12 | M45694 |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | NFASC IRAG1 CCN4 RBMS3 CACNA1H NOTCH3 THSD7B IGFBP7 TLE2 LPP | 1.11e-08 | 182 | 201 | 10 | 2075efeae633550fb2eb026d0dfd741c8252482e |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | NFASC IRAG1 CCN4 RBMS3 CACNA1H DOCK6 NOTCH3 THSD7B IGFBP7 LPP | 1.30e-08 | 185 | 201 | 10 | ba5baa4d7f097108622674de5b7f4fd279843d24 |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.43e-07 | 181 | 201 | 9 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 1.57e-07 | 183 | 201 | 9 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IRAG1 RBMS3 TBC1D1 CACNA1H SLC16A11 WDR90 NOTCH3 NCKAP5L LPP | 1.73e-07 | 185 | 201 | 9 | 38486b69c48dc5e1c4e1488208fa8954a973eccb |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IRAG1 RBMS3 TBC1D1 CACNA1H SLC16A11 WDR90 NOTCH3 NCKAP5L LPP | 1.73e-07 | 185 | 201 | 9 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NFASC IRAG1 CACNA1H NOTCH3 COL18A1 FAM153B IGFBP7 LPP ADAM33 | 2.70e-07 | 195 | 201 | 9 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NFASC IRAG1 CACNA1H NOTCH3 COL18A1 FAM153B IGFBP7 LPP ADAM33 | 2.70e-07 | 195 | 201 | 9 | a52ee3ad6cd317f10b9308450517861ef2e363bb |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NFASC IRAG1 CACNA1H NOTCH3 COL18A1 FAM153B IGFBP7 LPP ADAM33 | 2.70e-07 | 195 | 201 | 9 | b3660779f274ca97dd844cf83f62d85ba88cb182 |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-07 | 197 | 201 | 9 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-07 | 197 | 201 | 9 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.57e-07 | 159 | 201 | 8 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-07 | 161 | 201 | 8 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 7.57e-07 | 162 | 201 | 8 | a957c7e347189b72fbd47db3075bb5e879a21c67 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 169 | 201 | 8 | d6ad3b637de2935c656aad47ad82d6e8a8bd1227 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 169 | 201 | 8 | 60ef186518d0dc63dbded2a77c65cfe3129df754 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.19e-06 | 172 | 201 | 8 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.35e-06 | 175 | 201 | 8 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.60e-06 | 179 | 201 | 8 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 2.05e-06 | 185 | 201 | 8 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 2.05e-06 | 185 | 201 | 8 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 2.13e-06 | 186 | 201 | 8 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.22e-06 | 187 | 201 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 2.22e-06 | 187 | 201 | 8 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.22e-06 | 187 | 201 | 8 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.31e-06 | 188 | 201 | 8 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-06 | 189 | 201 | 8 | 0daa8efac08dca9525d2b8d421952068cab4eb50 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-06 | 189 | 201 | 8 | b6bb4327b4560d07d2b728abcc5f144f428948a5 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.50e-06 | 190 | 201 | 8 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.50e-06 | 190 | 201 | 8 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.50e-06 | 190 | 201 | 8 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-06 | 193 | 201 | 8 | 7631bf3362b4fa061ffeab4879ab12c4708dc4c0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-06 | 193 | 201 | 8 | 8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-06 | 196 | 201 | 8 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-06 | 196 | 201 | 8 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-06 | 196 | 201 | 8 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-06 | 196 | 201 | 8 | 8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-06 | 196 | 201 | 8 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-06 | 196 | 201 | 8 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-06 | 197 | 201 | 8 | d16bb765afdc02406ffd7ce6a75bae72b66db66c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-06 | 198 | 201 | 8 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-06 | 198 | 201 | 8 | 882710bd6215e299257dd3df234292db9a2823ba | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-06 | 198 | 201 | 8 | b58138581f1a9073267d64c1211c5b9b4de71d3e | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-06 | 198 | 201 | 8 | e967c601101361fc1c48dab0e5b76dc68813276e | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-06 | 199 | 201 | 8 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.66e-06 | 200 | 201 | 8 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.10e-06 | 156 | 201 | 7 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-05 | 166 | 201 | 7 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.11e-05 | 167 | 201 | 7 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-05 | 169 | 201 | 7 | 9c9bb1b32fc6e22359424a262178906c3954415d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 170 | 201 | 7 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 170 | 201 | 7 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 171 | 201 | 7 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 171 | 201 | 7 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 171 | 201 | 7 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 171 | 201 | 7 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.29e-05 | 171 | 201 | 7 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 172 | 201 | 7 | c0bda7153e02bee7d0326138cc684151c404c2a1 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-05 | 172 | 201 | 7 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-05 | 172 | 201 | 7 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.34e-05 | 172 | 201 | 7 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-05 | 173 | 201 | 7 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 174 | 201 | 7 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-05 | 174 | 201 | 7 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 177 | 201 | 7 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 177 | 201 | 7 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-05 | 177 | 201 | 7 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 178 | 201 | 7 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-05 | 179 | 201 | 7 | d96741c5c551e36421b2ad938072ab7d506c3835 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.80e-05 | 180 | 201 | 7 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 180 | 201 | 7 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 181 | 201 | 7 | 709e9c7a60d5f98635b99895ce30bb87a9f7376d | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 2.00e-05 | 183 | 201 | 7 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-05 | 183 | 201 | 7 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-05 | 183 | 201 | 7 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 184 | 201 | 7 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-05 | 184 | 201 | 7 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 184 | 201 | 7 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 185 | 201 | 7 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.15e-05 | 185 | 201 | 7 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 185 | 201 | 7 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-05 | 187 | 201 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 187 | 201 | 7 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 187 | 201 | 7 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 187 | 201 | 7 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-05 | 188 | 201 | 7 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 188 | 201 | 7 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 189 | 201 | 7 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 189 | 201 | 7 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 189 | 201 | 7 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 189 | 201 | 7 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 189 | 201 | 7 | 2b5f1b4f173a224342ea4f10b193ee33b7662699 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 2.46e-05 | 189 | 201 | 7 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 189 | 201 | 7 | 43e131458d8a4b120f7a5fb3d0c5650abded15f6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 190 | 201 | 7 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 190 | 201 | 7 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 190 | 201 | 7 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 190 | 201 | 7 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 191 | 201 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-05 | 191 | 201 | 7 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | KIF1A C15orf39 PLD3 CIC NFKB2 DCAF15 DIDO1 EML3 COL18A1 LPP CABIN1 | 5.18e-07 | 191 | 186 | 11 | 5351_DN |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | MAPT PPRC1 C15orf39 UAP1L1 NOTCH3 RARA BHLHE40 IER2 SLF2 LPP | 3.70e-06 | 189 | 186 | 10 | 5203_DN |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | C15orf39 ADCY6 NFKB2 BAHCC1 EP400 CBX4 SIM2 EML3 CABIN1 INO80B | 4.89e-06 | 195 | 186 | 10 | 3523_DN |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; PC3; HT_HG-U133A | CDKN1C KIF1A NAA80 PLD3 PTGS2 UAP1L1 NOTCH3 CCDC85C MICALL1 CABIN1 | 5.11e-06 | 196 | 186 | 10 | 4204_DN |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | CDKN1C MAPT CC2D1A PTGS2 BATF3 DCAF15 CCDC85C CBX4 CABIN1 INO80B | 5.59e-06 | 198 | 186 | 10 | 6603_DN |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 5.85e-06 | 199 | 186 | 10 | 3430_DN | |
| Drug | rottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.14e-05 | 170 | 186 | 9 | 941_UP | |
| Drug | GW8510; Up 200; 10uM; PC3; HT_HG-U133A | 2.33e-05 | 186 | 186 | 9 | 7067_UP | |
| Drug | alprazolam | 3.12e-05 | 193 | 186 | 9 | CID000002118 | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 3.12e-05 | 193 | 186 | 9 | 5839_DN | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 3.12e-05 | 193 | 186 | 9 | 4973_DN | |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A | 3.25e-05 | 194 | 186 | 9 | 2840_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 3.25e-05 | 194 | 186 | 9 | 4001_DN | |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.38e-05 | 195 | 186 | 9 | 2795_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.38e-05 | 195 | 186 | 9 | 5357_DN | |
| Drug | DO 897/99; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 2877_UP | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 7419_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 4948_DN | |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 5528_DN | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.66e-05 | 197 | 186 | 9 | 2782_UP | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.66e-05 | 197 | 186 | 9 | 1697_DN | |
| Drug | Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | 3.66e-05 | 197 | 186 | 9 | 2384_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A | 3.81e-05 | 198 | 186 | 9 | 4971_DN | |
| Drug | Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.81e-05 | 198 | 186 | 9 | 4482_DN | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | B4GALT2 KIF1A CACNA1H DOCK6 BAHCC1 RARA BAHD1 MICALL1 SHARPIN | 3.81e-05 | 198 | 186 | 9 | 6040_DN |
| Drug | 2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A | 3.96e-05 | 199 | 186 | 9 | 346_DN | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.96e-05 | 199 | 186 | 9 | 7365_DN | |
| Drug | AC1NBU2S | 5.05e-05 | 117 | 186 | 7 | CID004473765 | |
| Drug | allylpyrocatechol | 6.17e-05 | 10 | 186 | 3 | ctd:C523074 | |
| Drug | AC1N6UEL | 6.17e-05 | 10 | 186 | 3 | CID004221373 | |
| Drug | leflunomide | 7.02e-05 | 85 | 186 | 6 | CID000003899 | |
| Drug | NSC-692968 | 7.02e-05 | 85 | 186 | 6 | CID000392472 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.46e-05 | 168 | 186 | 8 | 6820_DN | |
| Disease | mean reticulocyte volume | MAPT PPRC1 C15orf39 ZNF469 KAT2B TONSL VPS37D RETREG2 EP400 BAHD1 E2F8 TGIF1 KLF16 SLC7A10 MYO16 CDH15 | 3.64e-05 | 799 | 181 | 16 | EFO_0010701 |
| Disease | monocyte count | IRAG1 CIC RYR1 CABLES1 NCR3 LY6G6F NYAP1 VPS37D NPAT RETREG2 SH2B3 JADE2 DIDO1 TGIF1 EGF LPP FCRLB CABIN1 SLC7A10 MYO16 | 1.86e-04 | 1320 | 181 | 20 | EFO_0005091 |
| Disease | Squamous cell carcinoma of esophagus | 3.05e-04 | 95 | 181 | 5 | C0279626 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.70e-04 | 5 | 181 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 3.70e-04 | 5 | 181 | 2 | C0010701 | |
| Disease | Thyroid preparation use measurement | 4.03e-04 | 217 | 181 | 7 | EFO_0009933 | |
| Disease | Agouti-related protein measurement | 5.96e-04 | 27 | 181 | 3 | EFO_0008016 | |
| Disease | Parkinsonism (implicated_via_orthology) | 7.38e-04 | 29 | 181 | 3 | DOID:0080855 (implicated_via_orthology) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 7.70e-04 | 7 | 181 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | platelet component distribution width | SVEP1 CABLES1 NYAP1 VPS37D GP1BB SH2B3 TENT4A JADE2 MICALL1 COL18A1 EGF LPP ADAM33 | 8.25e-04 | 755 | 181 | 13 | EFO_0007984 |
| Disease | lung cancer (implicated_via_orthology) | 1.31e-03 | 9 | 181 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | Creutzfeldt-Jakob disease (is_marker_for) | 1.63e-03 | 10 | 181 | 2 | DOID:11949 (is_marker_for) | |
| Disease | Profound Mental Retardation | 1.70e-03 | 139 | 181 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.70e-03 | 139 | 181 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.70e-03 | 139 | 181 | 5 | C0917816 | |
| Disease | hypothyroidism | 1.93e-03 | 284 | 181 | 7 | EFO_0004705 | |
| Disease | monocyte percentage of leukocytes | TBC1D1 SEC16A VPS37D BAHCC1 SH2B3 JADE2 C16orf96 TGIF1 EGF LPP SLC7A10 MYO16 | 1.94e-03 | 731 | 181 | 12 | EFO_0007989 |
| Disease | Microphthalmos | 1.98e-03 | 11 | 181 | 2 | C0026010 | |
| Disease | diabetic nephropathy, type 2 diabetes mellitus | 1.98e-03 | 11 | 181 | 2 | EFO_0000401, MONDO_0005148 | |
| Disease | respiratory system disease | 2.05e-03 | 145 | 181 | 5 | EFO_0000684 | |
| Disease | eosinophil count | MAPT MCIDAS SVEP1 CABLES1 TBC1D1 SEC16A MAP3K11 CACNA1H BATF3 BAHCC1 SH2B3 TENT4A KCP C16orf96 C9orf163 LPP SHARPIN SLC7A10 MYO16 | 2.06e-03 | 1488 | 181 | 19 | EFO_0004842 |
| Disease | Neoplasm Metastasis | 2.28e-03 | 217 | 181 | 6 | C0027627 | |
| Disease | Seizures | 2.34e-03 | 218 | 181 | 6 | C0036572 | |
| Disease | age at menopause | 2.72e-03 | 302 | 181 | 7 | EFO_0004704 | |
| Disease | obsolete_interleukin-12 subunit B measurement | 3.24e-03 | 14 | 181 | 2 | EFO_0010787 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 3.24e-03 | 14 | 181 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | platelet measurement | 3.42e-03 | 315 | 181 | 7 | EFO_0005036 | |
| Disease | Generalized seizures | 3.52e-03 | 101 | 181 | 4 | C0234533 | |
| Disease | Clonic Seizures | 3.52e-03 | 101 | 181 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 3.52e-03 | 101 | 181 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 3.52e-03 | 101 | 181 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 3.52e-03 | 101 | 181 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 3.52e-03 | 101 | 181 | 4 | C0751123 | |
| Disease | Complex partial seizures | 3.52e-03 | 101 | 181 | 4 | C0149958 | |
| Disease | Single Seizure | 3.52e-03 | 101 | 181 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 3.52e-03 | 101 | 181 | 4 | C3495874 | |
| Disease | Visual seizure | 3.52e-03 | 101 | 181 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 3.52e-03 | 101 | 181 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 3.52e-03 | 101 | 181 | 4 | C0422855 | |
| Disease | Gustatory seizure | 3.52e-03 | 101 | 181 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 3.52e-03 | 101 | 181 | 4 | C0422850 | |
| Disease | Olfactory seizure | 3.52e-03 | 101 | 181 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 3.52e-03 | 101 | 181 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 3.52e-03 | 101 | 181 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 3.52e-03 | 101 | 181 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 3.52e-03 | 101 | 181 | 4 | C4317109 | |
| Disease | Absence Seizures | 3.65e-03 | 102 | 181 | 4 | C4316903 | |
| Disease | Convulsions | 3.65e-03 | 102 | 181 | 4 | C4048158 | |
| Disease | Tonic Seizures | 3.65e-03 | 102 | 181 | 4 | C0270844 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 3.73e-03 | 15 | 181 | 2 | EFO_0010367 | |
| Disease | Mood Disorders | 3.86e-03 | 168 | 181 | 5 | C0525045 | |
| Disease | Seizures, Focal | 3.91e-03 | 104 | 181 | 4 | C0751495 | |
| Disease | Myoclonic Seizures | 3.91e-03 | 104 | 181 | 4 | C4317123 | |
| Disease | Tonic - clonic seizures | 3.91e-03 | 104 | 181 | 4 | C0494475 | |
| Disease | Dermatitis | 4.24e-03 | 16 | 181 | 2 | C0011603 | |
| Disease | Liver carcinoma | 4.24e-03 | 507 | 181 | 9 | C2239176 | |
| Disease | autoimmune disease | 4.37e-03 | 173 | 181 | 5 | EFO_0005140 | |
| Disease | susceptibility to common cold measurement | 4.48e-03 | 54 | 181 | 3 | EFO_0008417 | |
| Disease | Dementia | 4.79e-03 | 17 | 181 | 2 | C0497327 | |
| Disease | caudal anterior cingulate cortex volume measurement | 4.79e-03 | 17 | 181 | 2 | EFO_0010289 | |
| Disease | Alzheimer's disease (is_marker_for) | 5.22e-03 | 257 | 181 | 6 | DOID:10652 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | 5.31e-03 | 525 | 181 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.31e-03 | 525 | 181 | 9 | C1257931 | |
| Disease | Dystonia, Paroxysmal | 5.37e-03 | 18 | 181 | 2 | C0393588 | |
| Disease | Gastric ulcer | 5.37e-03 | 18 | 181 | 2 | C0038358 | |
| Disease | autoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease | 5.37e-03 | 18 | 181 | 2 | EFO_0003779, EFO_0004237, EFO_0006812 | |
| Disease | Mammary Neoplasms | 5.44e-03 | 527 | 181 | 9 | C1458155 | |
| Disease | Endometrial Neoplasms | 5.47e-03 | 58 | 181 | 3 | C0014170 | |
| Disease | Carcinoma, Granular Cell | 5.75e-03 | 116 | 181 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.75e-03 | 116 | 181 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.75e-03 | 116 | 181 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.75e-03 | 116 | 181 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.75e-03 | 116 | 181 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 5.75e-03 | 116 | 181 | 4 | C0001418 | |
| Disease | basophil measurement | 6.01e-03 | 60 | 181 | 3 | EFO_0803539 | |
| Disease | Antihypertensive use measurement | 6.04e-03 | 265 | 181 | 6 | EFO_0009927 | |
| Disease | non-melanoma skin carcinoma | 6.04e-03 | 265 | 181 | 6 | EFO_0009260 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VASTRLPVDPAPPCP | 681 | Q96L91 | |
| PSFCVPLDVPAEPGP | 406 | P43681 | |
| PLDVPAEPGPSCKSP | 411 | P43681 | |
| TFLPGEPPPCSPRSL | 1131 | Q9P281 | |
| EPPPCSPRSLEEPGL | 1136 | Q9P281 | |
| APTLPPCPDSPPGLV | 91 | O60909 | |
| PAGPPTCSVPPASAL | 161 | Q96B36 | |
| PGLALPCPSPLVTPT | 246 | Q6ZW13 | |
| SRISGPIPPDPTLCP | 6 | Q9H0I2 | |
| QPPLPGFDSCLPVVP | 1076 | Q9NP73 | |
| FCVPPGASPEVPKPA | 746 | Q2NKJ3 | |
| GPCPPSLLPATDKPS | 506 | Q9NS82 | |
| CLRDAEPPSPTPAGP | 46 | O43306 | |
| PRCLTPEPSPALVPS | 586 | A1IGU5 | |
| VGPSPSPAAPICFFP | 121 | Q8N9P6 | |
| SPGPSPAFLSCPPSL | 31 | P0CZ25 | |
| SAQPPPACLPKAPGL | 6 | O14503 | |
| SPEPPGPPARSCVAA | 11 | Q7Z5M8 | |
| SNAPDPGLPVPPALC | 406 | Q9BZ11 | |
| PPSPPRCPLGVSLIT | 56 | O95388 | |
| APGATTSLPPFPPLC | 501 | Q8TAP6 | |
| PACRSPGPSPPIAVA | 36 | Q8N1I8 | |
| FVPVPPRPDPVAGCL | 111 | Q9NR55 | |
| DSEPVPASLCPQPAP | 961 | Q8TE57 | |
| PPCPSQTGSPPVGLI | 626 | Q8WWM7 | |
| PPECLLTPLPPSADD | 266 | Q92617 | |
| SLAVCEESPPPPAPE | 81 | Q15032 | |
| KTPPGVPAPSDPLLC | 201 | Q15434 | |
| KTPPGIPAPSEPLLC | 206 | Q6XE24 | |
| GLAPPPGSCSPSLSP | 436 | P10276 | |
| VPPSEALPPPACPSA | 336 | Q3YEC7 | |
| ALLPTPVEPTAACGP | 446 | O94810 | |
| CLLTPLPPSAPPSVD | 311 | Q9UND3 | |
| PPECVLTPLPPSADD | 266 | F8W0I5 | |
| ALGEAVELPCPSPPT | 26 | Q5SQ64 | |
| VPPVTPDLPACSPAS | 1306 | Q14207 | |
| APSCPLAPRDPGPAA | 846 | Q96JH8 | |
| GPLFPPPELACEPVQ | 456 | Q9BY79 | |
| LPPEPPETGVSHLCP | 666 | Q5HY64 | |
| PPPLCPSGRTPDLKA | 296 | Q8IV08 | |
| PCLPPESPASALEPE | 811 | Q96DN6 | |
| SCPPRPEPELPADVS | 251 | Q96EL1 | |
| AAAPGPCAPSPFPEV | 31 | Q6ZWB6 | |
| LPRALPSCGPASPPA | 426 | Q8NCK7 | |
| LPCSLAGSPAPSPAP | 231 | Q9BXK1 | |
| CLCPGLSSPAQPPDP | 71 | Q8ND94 | |
| LPAVVPAPLPPPCGS | 176 | O14931 | |
| PAPLPPPCGSSAHLL | 181 | O14931 | |
| EVLRSPGVPPSPCLP | 596 | Q9HCH0 | |
| ALPPAPPQGSPCAAA | 31 | Q92831 | |
| PLPECLTISPPVPSG | 246 | Q93015 | |
| TPQCALPPAAPPGDE | 1391 | Q9Y6X6 | |
| PLLVFPPTPVTCSPA | 1491 | Q9Y6X6 | |
| SGILQTSPPPAPPCL | 421 | Q2KJY2 | |
| TSPPPAPPCLLRAVN | 426 | Q2KJY2 | |
| TLVPTPPPELPTDCG | 511 | P98073 | |
| GPACPAPELPSPPSA | 326 | A6NKD9 | |
| LAPPSRPAAGCPAPC | 16 | P13224 | |
| TPPGLDVCSGPPSPL | 206 | Q9Y6F6 | |
| AGDCPILATPESPPP | 661 | Q9NQC1 | |
| AGPSPPPPRCSLLEL | 56 | Q5XUX0 | |
| SLVPSPPPGPVELCV | 901 | P51805 | |
| PLCPPGAVELLCPAP | 821 | Q9ULL4 | |
| VCSVPPRLPPAAVPS | 4141 | Q9NYQ8 | |
| TPERLAACGPPPVAP | 46 | P18065 | |
| AACGPPPVAPPAAVA | 51 | P18065 | |
| LAPTPSAPCPATPAG | 336 | P10515 | |
| DPEAPAGRCLPLPPS | 326 | P39060 | |
| PPPPSPFLGVACAVA | 91 | A0A1B0GUS0 | |
| ASPARPCPSPGPAAA | 161 | Q9BQ89 | |
| LQPCSPACPPATGRP | 861 | O95644 | |
| GSLPPLCLPPSHPCA | 686 | Q9UM47 | |
| CPAPAPCPAPGISAL | 46 | Q8WX77 | |
| CGDPPPVAPSRLLPL | 56 | P52848 | |
| ITDPVSAPCAPPLQP | 356 | Q93052 | |
| RALPPVPDDCPTPLG | 136 | P35354 | |
| PPECLLTPLPPSADD | 266 | A8MRT5 | |
| GLAPCSPPSVAPTPV | 121 | Q8N3F8 | |
| PQPAKPCSGATPTPL | 591 | Q8N3F8 | |
| LSLGPRPPTPPCAVT | 501 | Q9UHC3 | |
| EPASCPPLPPLGCLL | 36 | Q16270 | |
| CLLTPLPPSAPPSVD | 311 | F8WFD2 | |
| PPECLLTPLPPSADD | 266 | C9JG80 | |
| PCDISPFGPCLSPPL | 146 | D6RGH6 | |
| PFGPCLSPPLDPRAL | 151 | D6RGH6 | |
| EPEPSVAEPPSCPLA | 46 | O14753 | |
| FTIPPPTLGVAPVPC | 656 | Q5XG87 | |
| PLPVAEGCPPPALTE | 196 | Q9C086 | |
| PPSLPPCPESAGAAT | 191 | A6NF01 | |
| TPCPALVPPTDSLGP | 526 | O75864 | |
| ECLLTPLPPSAPPSA | 306 | E5RHQ5 | |
| FAALSPGPPAPADPC | 16 | O00634 | |
| PGPEALCFPAPLAQP | 171 | O00634 | |
| CLFGPELPEDPPAAP | 141 | P06401 | |
| AAVPLPGDPPHALCP | 481 | Q5K4E3 | |
| TPPSLPPCPESAGAA | 606 | Q96HA1 | |
| APLTLQCNPPPGLPS | 156 | O94856 | |
| CLPELPPPPEGARAA | 121 | O14559 | |
| PCLAQPAAPAKVPSP | 1821 | O95996 | |
| PCLPEGADPSPPVVN | 1041 | Q9Y6J0 | |
| SGPCKPVAPLDPPVN | 466 | A0AVK6 | |
| TLNLPCCPLSPPASP | 1056 | Q96HP0 | |
| SGPCLPQPSSLPPLI | 136 | Q8TDN4 | |
| PAQPPALTPESAPGC | 306 | A6NNT2 | |
| EPGLICPDSTPPPHL | 946 | P01133 | |
| VPAPCPSPSAAPGVG | 291 | P49918 | |
| LGDTSPLPPTVPDCL | 651 | O14638 | |
| DITTAPGPPDQCKPP | 751 | Q9Y2H6 | |
| AALRSGAPIPDPCPP | 326 | Q6P531 | |
| GAPIPDPCPPFLQTA | 331 | Q6P531 | |
| CRLSLSPGAQPAPPP | 21 | Q96MF6 | |
| PSPTCPDLGAKSHPP | 181 | O00257 | |
| SRGEPVDLSCLPPPP | 301 | Q6P1N0 | |
| APGPPTSACPNVLTP | 31 | B7Z1M9 | |
| GHPEPSPLEDLSPCP | 936 | Q9BTC0 | |
| PLPSEAGPTPCAPAS | 306 | P08908 | |
| PASPAHPLLGCPVPS | 496 | Q8TBE0 | |
| HPLLGCPVPSVPPAA | 501 | Q8TBE0 | |
| LLPPRDLSPTAPCPA | 776 | Q674R7 | |
| LAAPPGLPPTCTPSL | 66 | Q32P44 | |
| APTAGPPACAPPTPL | 346 | Q6BAA4 | |
| PPACAPPTPLEQSAG | 351 | Q6BAA4 | |
| AADEPPSELVPGPPC | 56 | Q6ZMB0 | |
| LSGLSVPCPLPSPPA | 676 | O95180 | |
| VPCPLPSPPAGTLTC | 681 | O95180 | |
| CPLEKPGSPSATPAP | 2331 | O95180 | |
| PVPAAPLSAPGPCAA | 36 | Q8NFT8 | |
| PPPPSLFGDQPDLTC | 861 | Q12770 | |
| AAVCTPALRPPSPGP | 926 | Q12770 | |
| PPPNTPCPLELVDFG | 96 | Q9Y2W3 | |
| APPSALPAGAPPPCT | 3291 | P21817 | |
| PVLAPPPPGSLCSEP | 481 | P55291 | |
| PPAPTRPSCPAVAEI | 146 | Q99661 | |
| SLGPAAPPPPCIAAS | 1336 | Q5VV67 | |
| APPPPCIAASREPLD | 1341 | Q5VV67 | |
| LPPALPSFCPEAAPA | 291 | Q66K64 | |
| DLPAEEPAPSTPPCL | 311 | Q9UJU6 | |
| CPTEPPPSPLICFSL | 686 | Q16584 | |
| CPPRDPTVSIPELSP | 336 | O75309 | |
| PLCPPEILSETLPGS | 131 | P0C7A2 | |
| PCSRPASPEPELLPE | 1526 | Q12756 | |
| PPECVLTPLPPSADD | 266 | A6NJU9 | |
| LAPPACTPAAPAVPG | 271 | O96013 | |
| SPPVSLDPCAPAPAP | 326 | P78415 | |
| LNCSPAAPPTAPPAC | 186 | Q9BTL4 | |
| ICPKAAGAPAAPPAP | 431 | Q6ZVC0 | |
| EPGPTCAPSACLPPN | 11 | P41145 | |
| CPPPLLLAAAPGVPV | 121 | A1L443 | |
| CPPPLLLAAAPGVPV | 121 | Q5VZR2 | |
| SSPDPFPGLKPPCLA | 201 | A0A1W2PRP0 | |
| ALPNPCSPASVAPAP | 491 | Q9BST9 | |
| PPTPRVSADAAPDCP | 626 | Q9NXH9 | |
| APSALPSVPEPSAPC | 101 | Q96LD4 | |
| PLASASPAPPCGPFE | 1556 | A2VEC9 | |
| PLPATPTPLCSGPEA | 3226 | A2VEC9 | |
| SAPCAPAPAASGRPP | 116 | Q15270 | |
| CLLTPLPPSAPPSAD | 311 | E9PKD4 | |
| CPSLVGCPPSQLLPP | 1061 | Q6ZWJ8 | |
| EGPIPEPCALAPNPS | 191 | Q6ZRT6 | |
| PIPGQPCPSFPKSDV | 226 | O75603 | |
| PDPLACSLPPPKGFT | 211 | Q8IWB4 | |
| PPLCLVGSDPAPSPS | 451 | Q8NC44 | |
| CAPPTPEAPGAPAQL | 581 | Q14190 | |
| SPLPPEATLPSQCLP | 116 | A0A1B0GU29 | |
| GPAPPDAALCTSPRP | 71 | Q2M3G4 | |
| LCDPLASQPSPEPPL | 556 | Q2M3G4 | |
| SPPALGPEACPVSLP | 131 | Q9H0F6 | |
| GPEACPVSLPSPPEA | 136 | Q9H0F6 | |
| ASGPPEPLLPLKCPA | 221 | Q6ZUB1 | |
| LPLGDPSCVPTPRPA | 461 | Q9BR26 | |
| SCSPRASLPAPPLPG | 301 | A6NGB9 | |
| PPAALEVVPCIPSPA | 556 | Q8IX21 | |
| VPTLPAEPCSPFPQL | 41 | Q9H3Y6 | |
| PPLLLCAPPSSSGPT | 991 | E7EW31 | |
| CTPPPLISFGVPIPS | 2381 | Q4LDE5 | |
| RNPPPPSLCPEGLKS | 126 | E9PGG2 | |
| GVSPVPSPQLPPACA | 1071 | Q96RK0 | |
| LLPSADPPCSLAPAP | 166 | Q6ZRI6 | |
| CLPLPPRPPATSTAA | 226 | E7ERA6 | |
| PSALLGSSCAPPPPP | 71 | Q15583 | |
| PDPLACSLPPPKGFT | 211 | Q5VYP0 | |
| TETLLPGPRPCPSPL | 321 | O15417 | |
| PDECSLTPGSPPHPL | 61 | P0CAT3 | |
| GPQPLPCPVASSKPV | 251 | Q96KV7 | |
| PCGPPADAITSPPRS | 461 | Q5GH72 | |
| TAPAPAPGSPPCELS | 256 | Q8N8G2 | |
| PCEPLPGPLTQPRAH | 106 | O15027 | |
| PDPLACSLPPPKGFT | 211 | Q5VU36 | |
| PPEPEAPTTFCALLP | 16 | P98077 | |
| LLGTVLPPVPATPCP | 341 | Q9UH03 | |
| LFDPETSPPLSPCPE | 686 | Q96HA7 | |
| HGPPIPSALPPEDCT | 296 | Q6ZQQ2 | |
| LPPRSPLEPVCEDGP | 691 | Q86TI0 | |
| LPPNGDPPAICEISP | 456 | Q3KQV9 | |
| DSLPTVLPAPVPGCS | 181 | A8MX80 | |
| RDEGPPPAKLPCLSP | 271 | A8MX80 | |
| SPSDCPPALAPRPLS | 1031 | O94885 | |
| SEELAPPRPPGPCSF | 121 | Q9UQQ2 | |
| DPLIQPSSPAVCPEP | 421 | P10636 | |
| EACPEPSPLCPVPAG | 96 | Q6ZSY5 | |
| CPLGPAPLLSPRPSQ | 231 | Q86XT2 | |
| PPECLLTPLPPSADD | 281 | A6NJ64 | |
| ECPPPSLSPFPAALA | 3521 | Q96JG9 | |
| DPLPTVLPAPVPGCS | 151 | A8MV72 | |
| EKPGTTLPQPPPATC | 596 | Q86UK7 | |
| PPATCPPGALQAPEA | 606 | Q86UK7 | |
| GLLPSPHPACVPSPA | 716 | Q86UK7 | |
| EPAGSRSCPLPAPTP | 716 | Q8N398 | |
| DPLPTVLPAPVPGCS | 181 | Q8N9G6 | |
| DPLPTVLPAPVPGCS | 181 | A8MUI8 | |
| DPLPTVLPAPVPGCS | 181 | A8MUA0 | |
| LPPPLPAVCFSSAPL | 241 | Q9UIW0 | |
| LDPAVPAPLCPHGPT | 31 | Q9H5U6 | |
| PGPTPACSASRPEPL | 66 | Q9H7P9 | |
| ACSASRPEPLPGPPI | 71 | Q9H7P9 | |
| LPVGSVPAPACPPSL | 681 | Q9Y3S1 | |
| EDVSGSLCPVPPPPE | 576 | Q9C0I4 | |
| EPPSPATTPCGKVPI | 246 | Q04725 | |
| QPAAAPDAPCLGPSP | 11 | O94900 | |
| PLPAVLPAPVPDCSL | 181 | A6NL46 | |
| CTPQCASLEPGPPAP | 106 | Q2T9J0 | |
| LAPQESPSGPLEPCP | 476 | Q9BU19 | |
| SSPGPALPPGCVSRP | 36 | Q6ZQT7 | |
| PPAPAPTALATCIPE | 221 | Q5T230 | |
| QCSPPALPLSVPSPL | 1041 | O14686 | |
| PECPALEPSATSPLP | 1081 | O14686 | |
| PPESCCALPPRSLPS | 2391 | O14686 | |
| PPAEATGAPAPSRPC | 46 | P84157 | |
| TGAPAPSRPCAPEPA | 51 | P84157 | |
| PSRPCAPEPAASPAG | 56 | P84157 | |
| VPNPKGTPSPPCIVS | 196 | E9PAV3 | |
| EAGPPAVLSCLPEPP | 231 | O15049 | |
| PTPPLSPELPGSCRK | 1806 | B2RTY4 | |
| CASPQFEGPLSPPPI | 251 | Q96NK8 | |
| AENEEPLCPLPSPPT | 696 | Q00653 |